
K Patel Chemo-Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 1.13 M
- Company Age 50 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 21.00 Cr
- Satisfied Charges ₹ 3.90 Cr
- Revenue Growth 36.64%
- Profit Growth -6.55%
- Ebitda -10.65%
- Net Worth 9.95%
- Total Assets 11.99%
About K Patel Chemo-Pharma
K Patel Chemo-Pharma Private Limited (KPCPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 10 December 1974 and has a history of 50 years and two months. Its registered office is in Vadodara, Gujarat, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.13 M.
The company currently has active open charges totaling ₹21.00 Cr. The company has closed loans amounting to ₹3.90 Cr, as per Ministry of Corporate Affairs (MCA) records.
Mahendrabhai Patel, Jitendra Patel, Prerak Padsala, and Two other members serve as directors at the Company.
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24299GJ1974PTC002632
- Company No.
002632
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Dec 1974
- Date of AGM
14 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
What products or services does K Patel Chemo-Pharma Private Limited offer?
K Patel Chemo-Pharma Private Limited offers a wide range of products and services, including Reactive Dyes, Dischargeable Dyes.
Who are the key members and board of directors at K Patel Chemo-Pharma?
Executive Team (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Jitendra Patel ![]() | Managing Director | 10-Dec-1974 | Current |
Jitendra Patel ![]() | Managing Director | 18-Aug-1984 | Current |
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Mahendrabhai Patel ![]() | Director | 01-Feb-2003 | Current |
Prerak Padsala ![]() | Director | 01-Dec-2017 | Current |
Nilesh Patel ![]() | Director | 01-Apr-1992 | Current |
Financial Performance of K Patel Chemo-Pharma.
K Patel Chemo-Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 36.64% increase. The company also saw a slight decrease in profitability, with a 6.55% decrease in profit. The company's net worth moved up by a moderate rise of 9.95%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of K Patel Chemo-Pharma?
In 2022, K Patel Chemo-Pharma had a promoter holding of 99.00% and a public holding of 1.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Related Corporates (Common Directorship)
- K Patel Dye-Chem Industries Private Limited
Mahendrabhai Patel, Nilesh Patel and 1 more are mutual person
- Ankleshwar Research And Analytical Infrastructure Association
Jitendra Patel is a mutual person
- K. Patel Materials Private Limited
Prerak Padsala and Jitendra Patel are mutual person
- K Patel Lifesciences Private Limited
Nilesh Patel and Jitendra Patel are mutual person
Charges (Loans)
₹21.00 Cr
₹3.90 Cr
Charges Breakdown by Lending Institutions
- Others : 21.00 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
20 Sep 2024 | Others | ₹21.00 Cr | Open |
06 Oct 1995 | Bank Of Baroda | ₹3.90 Cr | Satisfied |
How Many Employees Work at K Patel Chemo-Pharma?
Unlock and access historical data on people associated with K Patel Chemo-Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Deals i

Gain comprehensive insights into the Deals and Valuation data of K Patel Chemo-Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped K Patel Chemo-Pharma's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.